Zoladex 10.8 MG implant syrns
Ended Awarded Last action
- Contract number
- SPE2DR26FM4T9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,798
Award facts
- Contract value 100% obligated
- $9,798.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $9,798.10 and a firm fixed price structure. This non-set-aside contract is set to complete by December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9 billion comprehensive pharmaceutical prime vendor agreement running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to provide this specialty pharmaceutical product supporting military and federal healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain, delivering a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Zoladex, a hormone therapy treatment, represents a routine execution under AmerisourceBergen's established prime vendor agreement that enables flexible pharmaceutical support to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM4T9?
SPE2DR26FM4T9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FM4T9 worth?
The government has obligated $9,798 on SPE2DR26FM4T9.
Is contract SPE2DR26FM4T9 an order under another contract?
Yes. SPE2DR26FM4T9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM4T9 competed?
The extent of competition for SPE2DR26FM4T9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award